Company Description

Cytotheryx, Inc. is a preclinical cell therapy company leveraging proprietary technology to address acute, chronic, and rare genetic liver diseases. A Mayo Clinic spinout, Cytotheryx has developed a differentiated platform that enables the scalable production of clinically relevant, fully functional primary human hepatocytes for therapeutic use.